← Open Payments lookup

JENNIFER RUSSO: Open Payments

NPI 1407200413 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,956 in 115 payments from 15 companies in 2025. Trend: 2023 $631 · 2024 $2,028 · 2025 $2,956

Food & beverage: $2,956
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)43$814
ABBVIE INC.27$659
Otsuka America Pharmaceutical, Inc.16$374
E.R. Squibb & Sons, L.L.C.5$183
Collegium Pharmaceutical, Inc.5$166
Alkermes, Inc.4$157
Axsome Therapeutics, Inc.2$149
Vanda Pharmaceuticals Inc.1$122
Tris Pharma Inc5$116
Janssen Pharmaceuticals, Inc1$95

Products named: CAPLYTA, VRAYLAR, COBENFY, Jornay PM, ARISTADA, REXULTI, Auvelity, FANAPT.

Industry payments across NV — which companies pay providers there.